US Patent Issued to Keros Therapeutics on June 17 for "ALK2 antibodies and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,124, issued on June 17, was assigned to Keros Therapeutics Inc. (Lexington, Mass.).

"ALK2 antibodies and methods of use thereof" was invented by Jasbir S. Seehra (Lexington, Mass.) and Jennifer Lachey (Lincoln, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention features ALK2 antibodies and antigen binding fragments thereof (e.g., ALK2 binding fragments). The invention also features pharmaceutical compositions and methods of using the ALK2 antibodies or antigen binding fragments thereof to treat bone disease or damage, low red blood cell levels (e.g., anemia or blood loss), heterotopic ossification (e.g., heterotopic ossification resu...